Nitai D. Mukhopadhyay
Affiliations: | Biostatistics | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Biostatistics BiologyGoogle:
"Nitai Mukhopadhyay"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ricco A, Mukhopadhyay N, Deng X, et al. (2020) Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial. Frontiers in Oncology. 10: 1686 |
| Ricco A, Mukhopadhyay N, Holdford D, et al. (2020) Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage. Journal of Clinical Oncology. 38: 299-299 |
| Fields EC, Kaplan BJ, Karlin J, et al. (2019) Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer. Advances in Radiation Oncology. 4: 605-612 |
| Karlin J, Allen J, Ahmad SF, et al. (2018) Orally bioavailable and blood-brain-barrier penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice. Molecular Cancer Therapeutics |
| Fields E, Kaplan B, Karlin J, et al. (2018) Overcoming the Barriers to the Use of Short Course Radiation Therapy in Locally Advanced Rectal Cancer: A Phase 1 Study of Short Course Radiation Therapy Concurrent with 5-Fluorouracil International Journal of Radiation Oncology*Biology*Physics. 102: e5 |
| Zhao S, Mahon R, Mukhopadhyay N, et al. (2018) Changes in Radiomic Features During Radiation Therapy as Predictors for Outcome in Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: S71 |
| Anscher MS, Chang MG, Moghanaki D, et al. (2016) The Effect of Lovastatin on Preservation of Erectile Function After Radiation Therapy (RT) for Prostate Cancer: Secondary Analysis of a Prospective Study. International Journal of Radiation Oncology, Biology, Physics. 96: E261-E262 |
| Anscher MS, Chang MG, Moghanaki D, et al. (2016) A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin. American Journal of Clinical Oncology |
| Chang MG, Saraiya S, Mukhopadhyay N, et al. (2016) Phase I/II study of hypofractionated intensity modulated radiotherapy (IMRT) for prostate cancer including simultaneously integrated boost (SIB). Journal of Clinical Oncology. 34: 67-67 |
| Anscher MS, Chang MG, Moghanaki D, et al. (2016) Phase II study of lovastatin to prevent rectal injury from radiation therapy for prostate cancer. Journal of Clinical Oncology. 34: 120-120 |